>>On the Market
Healthcare Professionals: Please visit the Aggrastat product website.
Medicure is currently developing a transdermal delivery formulation of its lead
AGGRASTAT (tirofiban HCl).
February 2, 2015
Medicure Provides Quarterly Revenue on a Calendar Basis Following Change to Year End Read more
January 27, 2015
Medicure Announces Shares for Debt SettlementsRead more
January 9, 2015
Medicure Announces Issuance of Shares Under Previously Announced Shares for Debt Settlement Read more
Sign up to receive email updates such as Press Release nofications and other company news.